These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17572033)

  • 1. [Tuberculosis treatment in 2007].
    Tattevin P
    Med Mal Infect; 2007 Oct; 37(10):617-28. PubMed ID: 17572033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the treatment of tuberculosis.
    Inge LD; Wilson JW
    Am Fam Physician; 2008 Aug; 78(4):457-65. PubMed ID: 18756652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996-2005.
    Mokaddas E; Ahmad S; Samir I
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):319-25. PubMed ID: 18284839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
    Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.
    Sneag DB; Schaaf HS; Cotton MF; Zar HJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1142-6. PubMed ID: 18043453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
    Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR
    Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of active tuberculosis.
    Potter B; Rindfleisch K; Kraus CK
    Am Fam Physician; 2005 Dec; 72(11):2225-32. PubMed ID: 16342845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis.
    Lalloo UG; Naidoo R; Ambaram A
    Curr Opin Pulm Med; 2006 May; 12(3):179-85. PubMed ID: 16582672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of extra-pulmonary tuberculosis.
    Drug Ther Bull; 1991 Apr; 29(7):26-8. PubMed ID: 1935605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent tuberculosis infection in children: a call for revised treatment guidelines.
    Finnell SM; Christenson JC; Downs SM
    Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 16. Reactivation of tuberculosis after apparently adequate chemoprophylaxis.
    Currie GP; Emmanuel FX; Ford D; Devereux G
    J Infect; 2005 Dec; 51(5):e305-8. PubMed ID: 16321645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran.
    Tabarsi P; Chitsaz E; Moradi A; Baghaei P; Farnia P; Marjani M; Irannejad P; Mansouri D; Masjedi M
    Int J STD AIDS; 2009 Aug; 20(8):566-70. PubMed ID: 19625590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case of pulmonary multi-drug resistant tuberculosis with left destroyed lung, treated with pneumonectomy].
    Koyama K; Kawakami K; Harada Y; Yamaryo T; Kimura Y
    Kekkaku; 2007 Jul; 82(7):577-81. PubMed ID: 17695788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and prevention of tuberculosis in HIV-infected patients: CDC guidelines.
    AIDS Read; 1999 Aug; 9(5):316-8, 323-6. PubMed ID: 12737121
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifapentine for the treatment of pulmonary tuberculosis.
    Munsiff SS; Kambili C; Ahuja SD
    Clin Infect Dis; 2006 Dec; 43(11):1468-75. PubMed ID: 17083024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.